Search clinical trials for: Intravesical Instillations

Total 280 results

M.D. Anderson Cancer Center
Bristol-Myers Squibb

Terminated

Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy

Bladder Cancer

United States
Centre Hospitalier Universitaire de Nīmes

Withdrawn

Effect of a Continuous Infusion of Esmolol on Stroke Volume in Patients With Hyperdynamic Vasoplegic Septic Shock (BétaSep)

Shock, Septic

France
Northwestern University

Terminated

Glaucoma Eye Drop Instillation: Impact of Education

Glaucoma, Open-Angle

United States
Mansoura University

Completed

Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer (NMIBCIVT)

Carcinoma of Urinary Bladder, Superficial

Egypt
Memorial Sloan Kettering Cancer Center
New York University; Novartis Pharmaceuticals; University of Hawaii

Completed

RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder

Bladder Cancer

United States
Mansoura University

Unknown

Delivery of Intravesical Botulinum Toxin A Using Low Energy Shock Waves in Treatment of Overactive Bladder: A Feasibility Study

Overactive Bladder | Botulinum Toxin | ESWL | Intravesical

Egypt
Seoul National University Hospital

Unknown

The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence

Urothelial Carcinoma

Korea, Republic of
Spectrum Pharmaceuticals, Inc

Completed

Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)

Bladder Cancer

Canada, United States, Poland
Peking University First Hospital

Unknown

Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients

Upper Tract Urothelial Carcinoma | Bladder Recurrence

China
Bioniche Life Sciences Inc.

Terminated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer (EMBARC-RF)

Carcinoma in Situ | Neoplasm Recurrence, Local | Bladder Neoplasm | Mycobacterium | Transitional Cell, Carcinoma

United States, Canada, Poland, Germany, Netherlands, United Kingdom
Shanghai Institute of Acupuncture, Moxibustion...

Completed

A Comparison of Electrical Ilioinguinal Nerve Stimulation With Intravesical Irrigation for Bladder Pain Syndrome

Painful Bladder Syndrome

China
FKD Therapies Oy

Completed

Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer

Superficial Bladder Cancer
UroGen Pharma Ltd.

Completed

Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC (OPTIMA)

Carcinoma of Urinary Bladder, Superficial

Israel, Spain, Italy, Switzerland
UroGen Pharma Ltd.

Completed

Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients

Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Bladder Cancer

Israel
Ankara Training and Research Hospital

Completed

In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?

Disease Progression | Bladder Cancer | Recurrent Bladder Cancer
Mansoura University

Unknown

Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects?

Non-Muscle-invasive Bladder Cancer (NMIBC) | Bacillus Calmette-Guerin (BCG) Cystitis | Intra-vesical Instillation

Egypt
Buddhist Tzu Chi General Hospital

Unknown

Comparative Study Suburothelial and Trigonal Botulinum Toxin A Injection in Treatment of Interstitial Cystitis

Bladder Pain Syndrome

Taiwan
Buddhist Tzu Chi General Hospital

Unknown

Platelet-Rich Plasma (PRP) Injection in Treatment of Interstitial Cystitis

Interstitial Cystitis

Taiwan
Hoffmann-La Roche

Completed

A Bioequivalence Study of Pegylated Interferon Alfa-2a (PEG-IFN Alfa-2a) Benzyl Alcohol (BA)-Free Formulation Versus PEG-IFN Alfa-2a (Pegasys) Following Subcutaneous Administration

Healthy Volunteers

New Zealand, Taiwan, Australia, Hong Kong, Singapore
Buddhist Tzu Chi General Hospital

Completed

Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial Cystitis

Interstitial Cystitis

Taiwan
Buddhist Tzu Chi General Hospital

Completed

Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment

Interstitial Cystitis

Taiwan
Kenneth Peters, MD

Completed

Intravesical Liposomes for Ulcerative Cystitis

Interstitial Cystitis

United States
Kenneth Peters, MD
William Beaumont Hospitals

Completed

Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)

Pelvic Pain | Interstitial Cystitis

United States
Loma Linda University

Completed

IVES for Treatment of UUI and OAB

Urinary Bladder, Overactive | Urinary Incontinence, Urge

United States
Spectrum Pharmaceuticals, Inc
Allergan

Terminated

Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer

Bladder Cancer

United States, Canada
M.D. Anderson Cancer Center
Flight Attendant Medical Research Institute

Completed

Markers of Response to Intravesical Bladder Cancer Therapy

Bladder Cancer

United States
M.D. Anderson Cancer Center
Gilead Sciences

Completed

Intravesical Cidofovir for Hemorrhagic Cystitis

Blood And Marrow Transplantation

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); FKD Therapies Oy of Finland

Completed

1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder Cancer

Bladder Cancer

United States
Peking University First Hospital

Unknown

Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients

Upper Tract Urothelial Carcinoma | Bladder Recurrence | Nephroureterectomy

China
UroGen Pharma Ltd.

Completed

Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients

Neoplasms | Urologic Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms

India
Bioniche Life Sciences Inc.

Completed

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

Bladder Neoplasms

Canada, United States
Sheba Medical Center

Unknown

Intravesically Heated Thermo-chemotherapy With Mitomycin-C Prior to TURBT

Transitional Cell Carcinoma

Israel
UroGen Pharma Ltd.

Terminated

Safety and Efficacy of Intravesical Botulinum Toxin in TC-3 Gel in OAB Patients

Overactive Bladder

Israel
Hillel Yaffe Medical Center

Completed

Induction of Labor in Patients With Unfavorable Cervical Conditions

Unfavorable Cervix for Induction of Labor

Israel
King Faisal Specialist Hospital & Research Center

Completed

Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder

Transitional Carcinoma of Urinary Bladder
The University of Texas Health Science Center at...

Completed

Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer

Urinary Bladder Neoplasm

United States
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University; New York Presbyterian Hospital

Terminated

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

Bladder Cancer

United States
Northwell Health

Withdrawn

Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis

Interstitial Cystitis

United States
Allergan
TARIS Biomedical, Inc.

Terminated

Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis

Interstitial Cystitis

United States, Canada
Xuesong Li

Unknown

Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas

Upper Tract Urothelial Carcinoma | Bladder Recurrence
UroGen Pharma Ltd.

Withdrawn

A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC) (NMIBC TURBT HG)

Non Muscle Invasive Bladder Cancer

Israel
Mark Dewhirst

Completed

Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer

Transitional Cell Carcinoma of Bladder | Superficial Bladder Cancer

United States
Endo Pharmaceuticals

Completed

Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) (Bladder Cancer)

Carcinoma in Situ | Bladder Cancer

United States
Endo Pharmaceuticals

Terminated

A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)

Bladder Cancer | CIS

United States
Abnoba Gmbh

Completed

Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer

Superficial Bladder Cancer

Egypt, Germany
National Cancer Institute (NCI)

Terminated

Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy

Stage III Bladder Cancer | Stage IV Bladder Cancer | Recurrent Bladder Carcinoma | Bladder Adenocarcinoma | Bladder Squamous Cell Carcinoma | Bladder Urothelial Carcinoma | Stage I Bladder Cancer | Stage II Bladder Cancer

United States
Assistance Publique - Hôpitaux de Paris

Completed

The Interest of the Nitrous Oxide During Intravesical Injection of Botulinum Toxin A (PROTOTOX)

Injection Site Vesicles

France
Medical Enterprises Europe B.V.

Terminated

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Neoplasms | Urologic Neoplasms | Neoplasms by Site | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Urinary Bladder Cancer | Malignant Tumor of Urinary Bladder

Austria, Israel, Italy, Netherlands
Solace Therapeutics, Inc.

Completed

The AttenueX IntraVesical System for the Treatment of Female Stress Urinary Incontinence

Urinary Incontinence, Stress

United States
Mayo Clinic

Completed

Botulin-A Toxin Instillations and Overactive Bladder

Overactive Bladder | Detrusor Instability | Detrusor Hyperreflexia

United States

3

Subscribe